BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32057731)

  • 1. Resveratrol prevented experimental pulmonary vascular remodeling via miR-638 regulating NR4A3/cyclin D1 pathway.
    Liu YY; Zhang WY; Wang CG; Huang JA; Jiang JH; Zeng DX
    Microvasc Res; 2020 Jul; 130():103988. PubMed ID: 32057731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol 3-Kinase-DNA Methyltransferase 1-miR-1281-Histone Deacetylase 4 Regulatory Axis Mediates Platelet-Derived Growth Factor-Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells.
    Li Y; Li L; Qian Z; Lin B; Chen J; Luo Y; Qu J; Raj JU; Gou D
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
    Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDGFBB promotes proliferation and migration via regulating miR-1181/STAT3 axis in human pulmonary arterial smooth muscle cells.
    Qian Z; Li Y; Yang H; Chen J; Li X; Gou D
    Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L965-L976. PubMed ID: 30211651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of NBL1 on PDGF-BB-induced human PASMC proliferation through blockade of PDGFβ-p38MAPK pathway.
    Cui C; Zhang H; Guo LN; Zhang X; Meng L; Pan X; Wei Y
    Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27474499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
    Paffett ML; Lucas SN; Campen MJ
    Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-34a-3p suppresses pulmonary vascular proliferation in acute pulmonary embolism rat by targeting DUSP1.
    Li Y; Shao J; Song J; Yu S; Wang J; Sun K
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34778900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
    Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
    Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension.
    Nogueira-Ferreira R; Ferreira-Pinto MJ; Silva AF; Vitorino R; Justino J; Costa R; Moreira-Gonçalves D; Quignard JF; Ducret T; Savineau JP; Leite-Moreira AF; Ferreira R; Henriques-Coelho T
    J Cell Physiol; 2017 Nov; 232(11):3128-3138. PubMed ID: 28036116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of neuron-derived orphan receptor 1 with pulmonary vascular remodeling in COPD patients.
    Wang CG; Li C; Lei W; Jiang JH; Huang JA; Zeng DX
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1177-1186. PubMed ID: 29695901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
    Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells.
    Price LC; Shao D; Meng C; Perros F; Garfield BE; Zhu J; Montani D; Dorfmuller P; Humbert M; Adcock IM; Wort SJ
    Respir Res; 2015 Sep; 16(1):114. PubMed ID: 26382031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of cyclin D1 by plasmid-based short hairpin RNA ameliorated experimental pulmonary vascular remodeling.
    Zeng DX; Xu GP; Lei W; Wang R; Wang CG; Huang JA
    Microvasc Res; 2013 Nov; 90():144-9. PubMed ID: 23948595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S; Haraguchi G; Sasaki A; Arai H; Muto S; Itai A; Doi S; Mizutani S; Isobe M
    Cardiovasc Res; 2013 Jul; 99(1):35-43. PubMed ID: 23631839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.